Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Drew
Drew holds a BA in Philosophy from the Templeton Honors College at Eastern University (summa cum laude) and a PhD in Philosophy from Boston College, where he is currently a fellow at the Lonergan Institute.
Anna
Anna graduated from Harvard University with a BA in English and a minor in Linguistics and Language Theory. While at Harvard, she was a curriculum editor for the Mamelodi Initiative in South Africa.